Guangna Liu
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 5
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 12
- Biotechnology top 2%
- Cancer Research and Treatments 5
- Microbiology top 5%
- Immunology top 10%
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 3
-
- Extracellular vesicles in disease 3
-
- Protease and Inhibitor Mechanisms 3
-
- Virus-based gene therapy research 2
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Guangna Liu
25 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Biomaterials 510
- Biomedical Engineering 1.2k
- Biotechnology 240
- Microbiology 145
- Immunology 333
Countries citing papers authored by Guangna Liu
This map shows the geographic impact of Guangna Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangna Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangna Liu more than expected).
Fields of papers citing papers by Guangna Liu
This network shows the impact of papers produced by Guangna Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangna Liu. The network helps show where Guangna Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guangna Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastomabreakdown → | 2025 | 21 |
| 3 | 2023 | 9 | |
| 4 | Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic fieldbreakdown → | 2023 | 151 |
| 5 | 2023 | 11 | |
| 6 | 2023 | 17 | |
| 7 | Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiomebreakdown → | 2022 | 134 |
| 8 | Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapybreakdown → | 2022 | 157 |
| 9 | 2021 | 29 | |
| 10 | 2020 | 124 | |
| 11 | 2020 | 224 | |
| 12 | Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacybreakdown → | 2019 | 356 |
| 13 | 2019 | 51 | |
| 14 | 2019 | 199 | |
| 15 | 2019 | 192 | |
| 16 | 2019 | 80 | |
| 17 | 2018 | 38 | |
| 18 | 2018 | 24 | |
| 19 | 2017 | 47 | |
| 20 | 2011 | 13 |
About Guangna Liu
Guangna Liu is a scholar working on Biotechnology, Biomaterials and Cancer Research, having authored 25 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Cancer Research and Treatments (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Extracellular vesicles in disease (3 papers), Immunotherapy and Immune Responses (3 papers), Protease and Inhibitor Mechanisms (3 papers), Immune cells in cancer (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Biomaterials (510 citations), Biomedical Engineering (1.2k citations) and Biotechnology (240 citations). Guangna Liu has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Guangjun Nie, Yinlong Zhang, Yao Li, Junchao Xu, Xiao Zhao, Keman Cheng, Jiaqi Xu, Huan Min, Jing Wang and Jian Shi. Their work appears in journals such as Advanced Materials, Nature Communications and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.